New York Times: “The First Covid Vaccine Will Not Make Life Normal Again”


Various pharmaceutical companies are on the race to make a successful coronavirus vaccine. Rushed clinical trials were allowed in order to speed up the process of vaccine development, but it also comes with great risks; it makes it difficult to determine which vaccine is better than the other, leaving a lot of room for random statistical errors, and overlooking long-term effects of vaccines. Once the first vaccine is approved by the Food and Drug Administration (FDA), the following vaccines will have to prove that they are able to provide more protection and are more effective than the approved one. This can take a very long time. In addition, with the number of vaccines with the potential to be put out on the market, the FDA—and consumers—will have to look out for potential long-term side effects of the rushed vaccines. Thus, even with a vaccine, there will be no return to normal, but a period of uncertainty and chaos. To read more, click here.

Comments are closed.

Skip to toolbar